Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now early-phase tilt small index

Cerebrovascular Disorders: early-phase trial registry

3 of 9 indexed Cerebrovascular Disorders trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

9 US clinical trials · 3 currently recruiting · #1,916 of 28,707 conditions by registered trial count

Cerebrovascular Disorders: 9 US clinical trials tracked, 3 recruiting.

Cerebrovascular Disorders is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is University of Wisconsin, Madison, running 2 of these trials.

Enrollment posture brief

Registry condition cerebrovascular-disorders

OPEN 3 | RECR 33% | LATE 1 | EARLY 2 | RANK #1916 | SPON 2

Volume-matched condition peers

Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)

Acute Lymphoblastic Leukemia55.6%Acute Respiratory Distress S55.6%Cerebrovascular Disorder (th…33%Acute Otitis Media22.2%Acute Heart Failure11.1%
Open-enrollment share among volume-matched conditions near Cerebrovascular Disorders

Cerebrovascular Disorders lists 3 open slots (33% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Cerebrovascular Disorders on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Cerebrovascular Disorders is recruiting below its size-band peers.

    3 of 9 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Cerebrovascular Disorders research.

    University of Wisconsin, Madison accounts for 2 of 9 trials (22.2%). 8 distinct sponsors appear on at least one study for this condition label.

  3. Typical Cerebrovascular Disorders enrolment sits around 340 participants.

    Median target enrolment is 340 among the 9 trials that report a genuine target (sentinel values excluded). 4 of those (44.4%) plan for fewer than 100 participants.

  4. Cerebrovascular Disorders splits between interventional and observational designs.

    5 interventional and 4 observational studies make up this index (55.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 41

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 4 1

Top Sponsors

University of Wisconsin, Madison 2 trials
Theranano 1 trials
Justin Fraser 1 trials
phenox 1 trials
National Heart, Lung, and Blood Institute (NHLBI) 1 trials
University of Southern California 1 trials
University of Pittsburgh 1 trials
Wake Forest University Health Sciences 1 trials

Named interventions

Most-linked intervention names on Cerebrovascular Disorders records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Quantitative Magnetic Resonance Imaging Diagnostic test
1 trials
Orilissa Drug
1 trials
Testosterone gel Drug
1 trials
Active Monitoring Behavioral
1 trials
Accelerated Skill Acquisition Program (ASAP) Behavioral
1 trials
Mechanical Thrombectomy using the Solitaire Revascularization Device Device
1 trials
Mechanical Thrombectomy using the pRESET Thrombectomy device Device
1 trials
iNO Drug
1 trials

US sites by state

Facility locations filed on Cerebrovascular Disorders trials. A trial with sites in several states counts in each.

Wisconsin 2 trials
Pennsylvania 2 trials
Massachusetts 2 trials
California 2 trials
Washington 1 trials
Texas 1 trials
Oregon 1 trials
Ohio 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Cerebrovascular Disorders page

9 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cerebrovascular Disorders condition card totals 9 registered trials; most-linked intervention Quantitative Magnetic Resonance Imaging; top US site state Wisconsin. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.